MARKET

REVB

REVB

Revelation Biosciences
NASDAQ
1.049
-0.061
-5.50%
After Hours: 1.047 -0.002 -0.20% 19:31 08/14 EDT
OPEN
1.140
PREV CLOSE
1.110
HIGH
1.140
LOW
1.034
VOLUME
31.38K
TURNOVER
--
52 WEEK HIGH
11.72
52 WEEK LOW
0.8750
MARKET CAP
4.18M
P/E (TTM)
-0.0854
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at REVB last week (0803-0807)?
Weekly Report · 4d ago
Revelation Biosciences (REVB) Gets a Buy from Roth MKM
TipRanks · 08/07 18:25
Revelation Biosciences GAAP EPS of -$0.87
Seeking Alpha · 08/07 13:38
Revelation Biosciences Q2 EPS $(0.87) Beats $(0.88) Estimate
Benzinga · 08/06 21:18
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in July 2026
Seeking Alpha · 08/03 13:45
Revelation Biosciences announces results from market assessment for Gemini
TipRanks · 08/03 13:15
Revelation Biosciences Cites Independent Market Assessment Indicating A $94B Total Addressable Market For Its Gemini Kidney Treatment
Benzinga · 08/03 13:03
Weekly Report: what happened at REVB last week (0727-0731)?
Weekly Report · 08/03 10:15
More
About REVB
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. The Company's product candidates are based on the Gemini formulation of phosphorylated hexaacyl disaccharide (PHAD). The Company has multiple ongoing programs to evaluate Gemini, including GEM-AKI as a prevention of acute kidney injury (AKI), GEM-CKD as a treatment for chronic kidney disease (CKD), and GEM-PSI as a prevention of post-surgical infection (PSI). The Gemini-AKI program is being developed as a potential therapy for the prevention of AKI due to external stress or insult, such as surgical procedure and chemotherapy toxicity. GEM-PSI is being developed as a potential therapy for the prevention or treatment of healthcare-associated bacterial infections, including post-surgical infection, post-burn infection, urinary tract infection, sepsis, and antibiotic-resistant infection.

Webull offers Revelation Biosciences Inc stock information, including NASDAQ: REVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REVB stock methods without spending real money on the virtual paper trading platform.